Genoray Co., Ltd. (122310) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Genoray Co., Ltd. (122310:KRX), powered by AI.

Current Price
₩3,570
P/E Ratio
68.6
Market Cap
52.0B
Sector
Healthcare
What is the Genoray Co., Ltd. stock price forecast?

Genoray Co., Ltd. is currently trading at ₩3,570. View real-time AI analysis on Alpha Lenz.

What is Genoray Co., Ltd. insider trading activity?

View the latest insider trading data for Genoray Co., Ltd. on Alpha Lenz.

What is Genoray Co., Ltd.'s P/E ratio?

Genoray Co., Ltd.'s P/E ratio is 68.6.

Genoray Co., Ltd.

KRX · 122310
₩3,570+70(+2.00%)Market closedKRX regular session 09:00–15:30 KST
Ask about Genoray Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Genoray Co., Ltd. trades at a P/E of 68.6 (premium valuation) with modest ROE of 0.9%.

Ask for details

Company Overview

Genoray Co., Ltd. is a prominent player in the medical technology industry, specializing in the development and production of advanced imaging equipment. The company focuses primarily on dental and medical radiology solutions which includes a comprehensive range of X-ray systems. These products are integral in diagnostic procedures across hospitals, dental clinics, and healthcare facilities, contributing significantly to improved patient care and precise diagnosis. Notably, Genoray’s offerings encompass portable and digital X-ray solutions, catering to diverse needs in medical imaging. Founded in 2001 and headquartered in South Korea, Genoray leverages its technological expertise to drive innovation in radiological imaging. The company's products are distinguished by their cutting-edge technology, precision, and user-friendly design, positioning them as reliable tools for medical professionals globally. Genoray's influence extends across various healthcare sectors, substantially impacting the fields of dentistry, orthopedics, and oncology. With a commitment to quality and advanced manufacturing processes, Genoray Co., Ltd. continues to enhance its footprint in the global medical equipment market, supporting health institutions in delivering accurate and efficient medical care.

CEO박병욱
SectorHealthcare
IndustryDiagnostics & Research
Employees346

Company Statistics

FY 2025

Profile

₩51,957,223,080Market Cap
₩108,042,067,260Revenue
14.55MShares Out
346Employees

Margins

38.55%Gross
7.77%EBITDA
-0.23%Operating
-1.05%Pre-Tax
0.58%Net

Valuation

68.57P/E
0.61P/B
0.48EV/Sales
8.50EV/EBITDA
13.48P/FCF

Growth (CAGR)

9.36%Rev 3Yr
11.86%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
-64.37%Net Inc 3Yr
-42.70%Net Inc 5Yr

Returns

0.49%ROA
0.89%ROE
-0.01%ROIC

Financial Health

₩13,837,287,630Cash & Cash Equivalents
₩33,640,168,330Net Debt
56.69%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Genoray Co., Ltd. (ticker: 122310) is a company listed on KRX in the Healthcare sector (Diagnostics & Research). It has approximately 346 employees. Market cap is $52.0B.

The current price is ₩3,570 with a P/E ratio of 68.57x and P/B of 0.61x.

ROE is 0.89% and operating margin is -0.23%. Annual revenue is $108.0B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Genoray Co., Ltd. (122310) Stock Forecast 2026 ₩3,570 — Price, Financials & Analyst Targets | Alpha Lenz